Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study).

McCarthy CP, van Kimmenade RRJ, Gaggin HK, Simon ML, Ibrahim NE, Gandhi P, Kelly N, Motiwala SR, Belcher AM, Harisiades J, Magaret CA, Rhyne RF, Januzzi JL Jr.

Am J Cardiol. 2017 Jul 1;120(1):25-32. doi: 10.1016/j.amjcard.2017.03.265. Epub 2017 Apr 12.

PMID:
28487034
2.

Type 2 myocardial infarction due to supply-demand mismatch.

Mihatov N, Januzzi JL Jr, Gaggin HK.

Trends Cardiovasc Med. 2017 Mar 11. pii: S1050-1738(17)30042-7. doi: 10.1016/j.tcm.2017.03.002. [Epub ahead of print] Review.

PMID:
28438399
3.

Systematic Evaluation of Endothelin 1 Measurement Relative to Traditional and Modern Biomarkers for Clinical Assessment and Prognosis in Patients With Chronic Systolic Heart Failure: Serial Measurement and Multimarker Testing.

Gaggin HK, Truong QA, Gandhi PU, Motiwala SR, Belcher AM, Weiner RB, Baggish AL, Januzzi JL Jr.

Am J Clin Pathol. 2017 Apr 7. doi: 10.1093/ajcp/aqx014. [Epub ahead of print]

PMID:
28398455
4.

A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive Coronary Artery Disease.

Ibrahim NE, Januzzi JL Jr, Magaret CA, Gaggin HK, Rhyne RF, Gandhi PU, Kelly N, Simon ML, Motiwala SR, Belcher AM, van Kimmenade RRJ.

J Am Coll Cardiol. 2017 Mar 7;69(9):1147-1156. doi: 10.1016/j.jacc.2016.12.021.

PMID:
28254177
5.

Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.

Gaggin HK, Liu Y, Lyass A, van Kimmenade RR, Motiwala SR, Kelly NP, Mallick A, Gandhi PU, Ibrahim NE, Simon ML, Bhardwaj A, Belcher AM, Harisiades JE, Massaro JM, D'Agostino RB Sr, Januzzi JL Jr.

Circulation. 2017 Jan 10;135(2):116-127. doi: 10.1161/CIRCULATIONAHA.116.023052. Epub 2016 Nov 21.

PMID:
27881568
6.

Circulating Concentrations of Orexin A Predict Left Ventricular Myocardial Remodeling.

Ibrahim NE, Rabideau DJ, Gaggin HK, Belcher AM, Conrad MJ, Jarolim P, Januzzi JL Jr.

J Am Coll Cardiol. 2016 Nov 15;68(20):2238-2240. doi: 10.1016/j.jacc.2016.08.049. No abstract available.

PMID:
27855816
7.

Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.

Gandhi PU, Gaggin HK, Redfield MM, Chen HH, Stevens SR, Anstrom KJ, Semigran MJ, Liu P, Januzzi JL Jr.

JACC Heart Fail. 2016 Nov;4(11):860-869. doi: 10.1016/j.jchf.2016.08.002. Epub 2016 Oct 12.

PMID:
27744089
8.

Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.

Motiwala SR, Gaggin HK.

Curr Heart Fail Rep. 2016 Oct;13(5):207-218. Review.

PMID:
27726056
9.

Associations Between Psychological Constructs and Cardiac Biomarkers After Acute Coronary Syndrome.

Celano CM, Beale EE, Beach SR, Belcher AM, Suarez L, Motiwala SR, Gandhi PU, Gaggin H, Januzzi JL Jr, Healy BC, Huffman JC.

Psychosom Med. 2017 Apr;79(3):318-326. doi: 10.1097/PSY.0000000000000404.

PMID:
27749683
10.

Serial Echocardiographic Characteristics, Novel Biomarkers and Cachexia Development in Patients with Stable Chronic Heart Failure.

Gaggin HK, Belcher AM, Gandhi PU, Ibrahim NE, Januzzi JL Jr.

J Cardiovasc Transl Res. 2016 Dec;9(5-6):429-431. Epub 2016 Sep 8.

PMID:
27631883
11.

Established and Emerging Roles of Biomarkers in Heart Failure Clinical Trials.

Ibrahim NE, Gaggin HK, Konstam MA, Januzzi JL Jr.

Circ Heart Fail. 2016 Sep;9(9). pii: e002528. doi: 10.1161/CIRCHEARTFAILURE.115.002528.

PMID:
27582282
12.

Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.

Ibrahim NE, Gaggin HK, Rabideau DJ, Gandhi PU, Mallick A, Januzzi JL Jr.

J Card Fail. 2017 Feb;23(2):121-130. doi: 10.1016/j.cardfail.2016.07.440. Epub 2016 Jul 25.

PMID:
27469482
13.

Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.

Gandhi PU, Chow SL, Rector TS, Krum H, Gaggin HK, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Carson PE, Januzzi JL Jr, Anand IS.

J Card Fail. 2017 Jan;23(1):20-28. doi: 10.1016/j.cardfail.2016.06.006. Epub 2016 Jun 16.

PMID:
27317843
14.

Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study.

Januzzi JL Jr, Lyass A, Liu Y, Gaggin H, Trebnick A, Maisel AS, D'Agostino RB Sr, Wang TJ, Massaro J, Vasan RS.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1692-7. doi: 10.1161/ATVBAHA.116.307847. Epub 2016 Jun 16.

PMID:
27312221
15.

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.

Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM; APEX Investigators.

N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27.

16.

The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy.

Mallick A, Gandhi PU, Gaggin HK, Ibrahim N, Januzzi JL.

JACC Heart Fail. 2016 Sep;4(9):749-55. doi: 10.1016/j.jchf.2016.03.012. Epub 2016 May 11.

PMID:
27179830
17.

Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study.

Lupón J, Sanders-van Wijk S, Januzzi JL, de Antonio M, Gaggin HK, Pfisterer M, Galán A, Shah R, Brunner-La Rocca HP, Bayes-Genis A.

Int J Cardiol. 2016 Feb 1;204:242-7. doi: 10.1016/j.ijcard.2015.11.163. Epub 2015 Nov 24.

PMID:
26682955
18.

Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome: The Gratitude Research in Acute Coronary Events Study.

Huffman JC, Beale EE, Celano CM, Beach SR, Belcher AM, Moore SV, Suarez L, Motiwala SR, Gandhi PU, Gaggin HK, Januzzi JL.

Circ Cardiovasc Qual Outcomes. 2016 Jan;9(1):55-63. doi: 10.1161/CIRCOUTCOMES.115.002184. Epub 2015 Dec 8.

19.

Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.

Brunner-La Rocca HP, Eurlings L, Richards AM, Januzzi JL, Pfisterer ME, Dahlström U, Pinto YM, Karlström P, Erntell H, Berger R, Persson H, O'Connor CM, Moertl D, Gaggin HK, Frampton CM, Nicholls MG, Troughton RW.

Eur J Heart Fail. 2015 Dec;17(12):1252-61. doi: 10.1002/ejhf.401. Epub 2015 Sep 30.

20.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators.

N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.

Supplemental Content

Loading ...
Support Center